Help
RSS
API
Feed
Maltego
Contact
Domain > www.dojolvihcp.com
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2025-01-01
104.18.26.217
(
ClassC
)
Port 80
HTTP/1.1 301 Moved PermanentlyDate: Sat, 28 Sep 2024 00:35:57 GMTContent-Type: text/htmlContent-Length: 167Connection: keep-aliveCache-Control: max-age3600Expires: Sat, 28 Sep 2024 01:35:57 GMTLocatio html>head>title>301 Moved Permanently/title>/head>body>center>h1>301 Moved Permanently/h1>/center>hr>center>cloudflare/center>/body>/html>
Port 443
HTTP/1.1 200 OKDate: Sat, 28 Sep 2024 00:35:57 GMTContent-Type: text/html; charsetUTF-8Transfer-Encoding: chunkedConnection: keep-aliveX-Powered-By: PHP/8.2.20Link: https://www.dojolvihcp.com/wp-json/ !doctype html>html langen-US>head> meta charsetUTF-8> meta http-equivX-UA-Compatible contentIE11> meta nameformat-detection contenttelephoneno> meta nameviewport contentwidthdevice-width, initial-scale1, maximum-scale1, user-scalableno> meta namegoogle-site-verification contentciNOJ8v7EHeJZGt8nC-dJ5dGZVCeZMOcDsh9AJdX6TA> !-- Google Tag Manager --> script>(function(w,d,s,l,i){wlwl||;wl.push({gtm.start: new Date().getTime(),event:gtm.js});var fd.getElementsByTagName(s)0, jd.createElement(s),dll!dataLayer?&l+l:;j.asynctrue;j.src https://www.googletagmanager.com/gtm.js?id+i+dl;f.parentNode.insertBefore(j,f); })(window,document,script,dataLayer,GTM-5S2LBN9);/script> !-- End Google Tag Manager --> meta namerobots contentnoindex, nofollow /> !-- This site is optimized with the Yoast SEO plugin v21.8 - https://yoast.com/wordpress/plugins/seo/ --> title>DOJOLVI® (triheptanoin) | LC Fatty Acid Oxidation Disorder/title> meta namedescription contentDOJOLVI® (triheptanoin) is the first and only FDA approved treatment for patients diagnosed with long chain fatty acid oxidation disorders (LC-FAOD) /> script typeapplication/ld+json classyoast-schema-graph>{@context:https://schema.org,@graph:{@type:WebPage,@id:https://www.dojolvihcp.com/,url:https://www.dojolvihcp.com/,name:DOJOLVI® (triheptanoin) | LC Fatty Acid Oxidation Disorder,isPartOf:{@id:https://www.dojolvihcp.com/#website},about:{@id:https://www.dojolvihcp.com/#organization},datePublished:2020-07-14T23:02:49+00:00,dateModified:2024-01-22T18:06:16+00:00,description:DOJOLVI® (triheptanoin) is the first and only FDA approved treatment for patients diagnosed with long chain fatty acid oxidation disorders (LC-FAOD),breadcrumb:{@id:https://www.dojolvihcp.com/#breadcrumb},inLanguage:en-US,potentialAction:{@type:ReadAction,target:https://www.dojolvihcp.com/}},{@type:BreadcrumbList,@id:https://www.dojolvihcp.com/#breadcrumb,itemListElement:{@type:ListItem,position:1,name:Home}},{@type:WebSite,@id:https://www.dojolvihcp.com/#website,url:https://www.dojolvihcp.com/,nam
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]